<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02492529</url>
  </required_header>
  <id_info>
    <org_study_id>2014-A01123-44</org_study_id>
    <secondary_id>35RC14_9777_EPMR-MA</secondary_id>
    <nct_id>NCT02492529</nct_id>
  </id_info>
  <brief_title>Knowing and Remembering: Cognitive and Neural Influences of Familiarity on Recognition Memory in Early Alzheimer's Disease</brief_title>
  <acronym>EPMR-MA</acronym>
  <official_title>Knowing and Remembering: Cognitive and Neural Influences of Familiarity on Recognition Memory in Early Alzheimer's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Unrandomized, unblinded, monocentric comparative Functional Magnetic Resonance Imaging study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective functional Magnetic Resonance Imaging study involving a group of participants
      with Mild Cognitive Impairment due to AD and a control participants group matched for age,
      education level, verbal Intelligence Quotient as assessed through the French version of the
      National Adult Reading Test and income group following National Institute of Statistics and
      Economics Studies classification.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 21, 2015</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of recognition memory accuracy measures under the familiarity condition as compared with the novel condition in the AD-MCI group</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Significant effect of the familiarity vs novelty condition on the pattern of % BOLD signal change in across the brain in the AD-MCI group</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Significant group effect on the pattern of % BOLD signal change in across the brain</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictive validity of the brain % BOLD signal change pattern for participants clinical status (i.e. controls vs. AD-MCI)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Significant interaction between the kind of familiarity condition (i.e. novel, experimental or pre-experimental) and the estimates of recognition memory processes efficiency (i.e. respective contributions of recollection and familiarity, % correct)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Alzheimer's Disease</condition>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>60 old healthy volunteers (aged 25-75) will undergo an inclusion visit in order to check inclusion and non inclusion criteria.
Then will be performed:
Neuropsychological tests
Experimental procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with early Alzheimer disease</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 patients (aged 60-75) will undergo an inclusion visit in order to check inclusion and non inclusion criteria.
Then will be performed:
Neuropsychological tests
Experimental procedure
A cranial MRI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Old healthy volunteers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 healthy volunteers (aged 60-75) will undergo an inclusion visit in order to check inclusion and non inclusion criteria.
Then will be performed:
Neuropsychological tests
Experimental procedure
A cranial MRI</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neuropsychological tests</intervention_name>
    <description>Scales and tests to evaluate:
Global cognitive performance
Handedness
Memory functions performance
Gestural praxis functions performance
Lexical and semantic functions performance
Executive functions performance
Memory disorders
Way of life
Mood</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with early Alzheimer disease</arm_group_label>
    <arm_group_label>Old healthy volunteers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>A cranial MRI</intervention_name>
    <arm_group_label>Patients with early Alzheimer disease</arm_group_label>
    <arm_group_label>Old healthy volunteers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental procedure</intervention_name>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with early Alzheimer disease</arm_group_label>
    <arm_group_label>Old healthy volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Volunteers (pilot phase)

          -  Aged 25 - 75

          -  French native speakers

          -  Right-handed

          -  Education level equal or superior to primary school leaving certificate

          -  Free from any medical or psychiatric condition that may impact cognition

          -  Having given written informed consent

        Volunteers (experimental phase)

          -  Aged 60 - 75

          -  French native speakers

          -  Right-handed

          -  Education level equal or superior to primary school leaving certificate

          -  Free from any medical or psychiatric condition that may impact cognition

          -  Having given written informed consent

        AD-MCI participants

          -  Aged 60 - 75

          -  French native speakers

          -  Right-handed

          -  Education level equal or superior to primary school leaving certificate

          -  Fulfilling criteria for &quot; AD-MCI &quot; (Albert et al., 2011)

          -  Have been seen in a memory medical center or in Memory Resources and Research Medical
             Center for cognitive symptoms

          -  Free from any medical or psychiatric condition that may impact cognition

          -  Able to understand and consent

          -  Having given written informed consent

        Exclusion Criteria:

        MRI contraindications (all participants)

          -  Claustrophobia

          -  Wearing of any metal implant such as:

               -  Heart pacemaker

               -  Iron-magnetic surgical clips

               -  Any metallic foreign body in the eye or brain

        Other criteria (all participants)

          -  Significant history of neurological or psychiatric disorders

          -  Ongoing medication that may affect cognitive performances

          -  Sensory deficit that may interfere with the experimental design (e.g. uncorrected
             visual impairment)

          -  Lack of sufficient cooperation during the cognitive tasks

          -  Persons under major legal protection and/or deprived of liberty

        Other criteria (control participants)

        - Global cognitive impairment attested by Mattis Dementia Rating Scale or Mini-Mental State
        Examination, according to available normative data

        Other criteria (AD-MCI participants)

          -  7 items modified Hachinski ischemic score &gt; 2 (Hachinski et al., 2012)

          -  Dementia (McKahn, et al., 2011)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2014</study_first_submitted>
  <study_first_submitted_qc>July 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2015</study_first_posted>
  <last_update_submitted>January 19, 2018</last_update_submitted>
  <last_update_submitted_qc>January 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Alzheimer, Recognition Memory, Mild Cognitive Impairment, fMRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

